Home Cart Sign in  
Chemical Structure| 1256589-74-8 Chemical Structure| 1256589-74-8

Structure of Alectinib HCl
CAS No.: 1256589-74-8

Chemical Structure| 1256589-74-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alectinib Hydrochloride (CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (ATP-competitive). It also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively, and demonstrates effective central nervous system (CNS) penetration.

Synonyms: CH5424802 Hydrochloride; RO5424802 Hydrochloride; RG-7853

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alectinib HCl

CAS No. :1256589-74-8
Formula : C30H35ClN4O2
M.W : 519.08
SMILES Code : N#CC1=CC2=C(C=C1)C3=C(C(C)(C)C4=CC(N5CCC(N6CCOCC6)CC5)=C(CC)C=C4C3=O)N2.[H]Cl
Synonyms :
CH5424802 Hydrochloride; RO5424802 Hydrochloride; RG-7853
MDL No. :MFCD27987893
InChI Key :GYABBVHSRIHYJR-UHFFFAOYSA-N
Pubchem ID :53239799

Safety of Alectinib HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Alectinib HCl

RTK

Isoform Comparison

Biological Activity

Description
Alectinib Hydrochloride (CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride) is a potent, selective, and orally available ALK inhibitor, exhibiting an IC50 of 1.9 nM and a KD value of 2.4 nM (in an ATP-competitive manner). Additionally, it inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01981005 Healthy Volunteer PHASE1 COMPLETED 2025-12-13 Zuidlaren, 9471 GP, Netherland... More >>s Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.63mL

1.93mL

0.96mL

19.26mL

3.85mL

1.93mL

References

 

Historical Records

Categories